Albers Jeffrey W. bought SYRE
August 7, 2026 · Form 4 insider transaction
Albers Jeffrey W. bought 5,000 shares of Spyre Therapeutics, Inc. at $10.39 per share, a transaction worth $52.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$10.39
Total value
$52.0K
InsiderAlbers Jeffrey W.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 7, 2026
Filing dateAugust 10, 2026
Shares owned after5,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.